HEADER LIGASE/INHIBITOR 30-NOV-20 7KWA TITLE STRUCTURE OF DCN1 BOUND TO N-((4S,5S)-3-(AMINOMETHYL)-7-ETHYL-4-(4- TITLE 2 FLUOROPHENYL)-6-OXO-1-PHENYL-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4- TITLE 3 B]PYRIDIN-5-YL)-3-(TRIFLUOROMETHYL)BENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOLYSIN,DCN1-LIKE PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LYSIS PROTEIN,LYSOZYME,MURAMIDASE,DCNL1,DCUN1 DOMAIN- COMPND 5 CONTAINING PROTEIN 1,DEFECTIVE IN CULLIN NEDDYLATION PROTEIN 1-LIKE COMPND 6 PROTEIN 1,SQUAMOUS CELL CARCINOMA-RELATED ONCOGENE; COMPND 7 EC: 3.2.1.17; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE RB59, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 697290, 9606; SOURCE 5 GENE: E, RB59_126, DCUN1D1, DCN1, DCUN1L1, RP42, SCCRO; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR COMPLEX, LIGASE, LIGASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.S.KIM,J.T.HAMMILL,B.A.SCHULMAN,R.K.GUY,D.C.SCOTT REVDAT 2 18-OCT-23 7KWA 1 REMARK REVDAT 1 14-JUL-21 7KWA 0 JRNL AUTH H.S.KIM,J.T.HAMMILL,D.C.SCOTT,Y.CHEN,A.L.RICE,W.PISTEL, JRNL AUTH 2 B.SINGH,B.A.SCHULMAN,R.K.GUY JRNL TITL IMPROVEMENT OF ORAL BIOAVAILABILITY OF PYRAZOLO-PYRIDONE JRNL TITL 2 INHIBITORS OF THE INTERACTION OF DCN1/2 AND UBE2M. JRNL REF J.MED.CHEM. V. 64 5850 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33945681 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00035 REMARK 2 REMARK 2 RESOLUTION. 1.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 49216 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 2431 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.0820 - 4.0412 0.89 2741 121 0.1852 0.1798 REMARK 3 2 4.0412 - 3.2082 0.92 2756 140 0.1613 0.1958 REMARK 3 3 3.2082 - 2.8028 0.94 2872 108 0.1775 0.2129 REMARK 3 4 2.8028 - 2.5466 0.85 2528 130 0.1726 0.2075 REMARK 3 5 2.5466 - 2.3641 0.94 2816 158 0.1633 0.2142 REMARK 3 6 2.3641 - 2.2248 0.95 2849 149 0.1559 0.1914 REMARK 3 7 2.2248 - 2.1134 0.96 2888 145 0.1603 0.2232 REMARK 3 8 2.1134 - 2.0214 0.96 2907 136 0.1611 0.2393 REMARK 3 9 2.0214 - 1.9436 0.91 2689 143 0.1618 0.2113 REMARK 3 10 1.9436 - 1.8765 0.86 2570 138 0.1612 0.2229 REMARK 3 11 1.8765 - 1.8178 0.93 2791 166 0.1613 0.2311 REMARK 3 12 1.8178 - 1.7659 0.94 2721 170 0.1696 0.2300 REMARK 3 13 1.7659 - 1.7194 0.94 2860 146 0.1653 0.2262 REMARK 3 14 1.7194 - 1.6774 0.95 2782 149 0.1657 0.2149 REMARK 3 15 1.6774 - 1.6393 0.94 2857 136 0.1720 0.2313 REMARK 3 16 1.6393 - 1.6044 0.91 2663 160 0.1807 0.2882 REMARK 3 17 1.6044 - 1.5723 0.83 2495 136 0.2060 0.2767 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.63 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KWA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000253271. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49253 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.34900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5V86 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6% PEG3350, 0.2M NH4BR, EVAPORATION, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.52850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -21 REMARK 465 GLY A -20 REMARK 465 SER A -19 REMARK 465 SER A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 THR A 1257 REMARK 465 THR A 1258 REMARK 465 VAL A 1259 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A -12 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A -10 CG CD OE1 NE2 REMARK 470 GLU A 22 CG CD OE1 OE2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 LYS A 147 CG CD CE NZ REMARK 470 ARG A1062 CG CD NE CZ NH1 NH2 REMARK 470 ASP A1096 CG OD1 OD2 REMARK 470 GLN A1120 CG CD OE1 NE2 REMARK 470 LYS A1149 CG CD CE NZ REMARK 470 GLU A1150 CG CD OE1 OE2 REMARK 470 LYS A1166 CG CD CE NZ REMARK 470 HIS A1203 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A1206 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1233 CG CD OE1 OE2 REMARK 470 ARG A1248 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1255 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A1115 -1.61 73.16 REMARK 500 MET A1227 17.95 57.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1777 DISTANCE = 6.43 ANGSTROMS REMARK 525 HOH A1778 DISTANCE = 6.54 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YHP A 1301 DBREF1 7KWA A 1 164 UNP A0A097J809_BPT4 DBREF2 7KWA A A0A097J809 1 164 DBREF 7KWA A 1062 1259 UNP Q96GG9 DCNL1_HUMAN 62 259 SEQADV 7KWA MET A -21 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA GLY A -20 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA SER A -19 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA SER A -18 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA HIS A -17 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA HIS A -16 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA HIS A -15 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA HIS A -14 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA HIS A -13 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA HIS A -12 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA SER A -11 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA GLN A -10 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA ASP A -9 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA LEU A -8 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA GLU A -7 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA ASN A -6 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA LEU A -5 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA TYR A -4 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA PHE A -3 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA GLN A -2 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA GLY A -1 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA SER A 0 UNP A0A097J80 EXPRESSION TAG SEQADV 7KWA THR A 54 UNP A0A097J80 CYS 54 CONFLICT SEQADV 7KWA ALA A 97 UNP A0A097J80 CYS 97 CONFLICT SEQADV 7KWA THR A 146 UNP A0A097J80 ALA 146 CONFLICT SEQRES 1 A 384 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 384 LEU GLU ASN LEU TYR PHE GLN GLY SER MET ASN ILE PHE SEQRES 3 A 384 GLU MET LEU ARG ILE ASP GLU GLY LEU ARG LEU LYS ILE SEQRES 4 A 384 TYR LYS ASP THR GLU GLY TYR TYR THR ILE GLY ILE GLY SEQRES 5 A 384 HIS LEU LEU THR LYS SER PRO SER LEU ASN ALA ALA LYS SEQRES 6 A 384 SER GLU LEU ASP LYS ALA ILE GLY ARG ASN THR ASN GLY SEQRES 7 A 384 VAL ILE THR LYS ASP GLU ALA GLU LYS LEU PHE ASN GLN SEQRES 8 A 384 ASP VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG ASN ALA SEQRES 9 A 384 LYS LEU LYS PRO VAL TYR ASP SER LEU ASP ALA VAL ARG SEQRES 10 A 384 ARG ALA ALA LEU ILE ASN MET VAL PHE GLN MET GLY GLU SEQRES 11 A 384 THR GLY VAL ALA GLY PHE THR ASN SER LEU ARG MET LEU SEQRES 12 A 384 GLN GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN LEU ALA SEQRES 13 A 384 LYS SER ARG TRP TYR ASN GLN THR PRO ASN ARG THR LYS SEQRES 14 A 384 ARG VAL ILE THR THR PHE ARG THR GLY THR TRP ASP ALA SEQRES 15 A 384 TYR LYS ASN LEU ARG LYS LYS LEU GLU GLN LEU TYR ASN SEQRES 16 A 384 ARG TYR LYS ASP PRO GLN ASP GLU ASN LYS ILE GLY ILE SEQRES 17 A 384 ASP GLY ILE GLN GLN PHE CYS ASP ASP LEU ALA LEU ASP SEQRES 18 A 384 PRO ALA SER ILE SER VAL LEU ILE ILE ALA TRP LYS PHE SEQRES 19 A 384 ARG ALA ALA THR GLN CYS GLU PHE SER LYS GLN GLU PHE SEQRES 20 A 384 MET ASP GLY MET THR GLU LEU GLY CYS ASP SER ILE GLU SEQRES 21 A 384 LYS LEU LYS ALA GLN ILE PRO LYS MET GLU GLN GLU LEU SEQRES 22 A 384 LYS GLU PRO GLY ARG PHE LYS ASP PHE TYR GLN PHE THR SEQRES 23 A 384 PHE ASN PHE ALA LYS ASN PRO GLY GLN LYS GLY LEU ASP SEQRES 24 A 384 LEU GLU MET ALA ILE ALA TYR TRP ASN LEU VAL LEU ASN SEQRES 25 A 384 GLY ARG PHE LYS PHE LEU ASP LEU TRP ASN LYS PHE LEU SEQRES 26 A 384 LEU GLU HIS HIS LYS ARG SER ILE PRO LYS ASP THR TRP SEQRES 27 A 384 ASN LEU LEU LEU ASP PHE SER THR MET ILE ALA ASP ASP SEQRES 28 A 384 MET SER ASN TYR ASP GLU GLU GLY ALA TRP PRO VAL LEU SEQRES 29 A 384 ILE ASP ASP PHE VAL GLU PHE ALA ARG PRO GLN ILE ALA SEQRES 30 A 384 GLY THR LYS SER THR THR VAL HET YHP A1301 64 HETNAM YHP N-[(4S,5S)-3-(AMINOMETHYL)-7-ETHYL-4-(4-FLUOROPHENYL)- HETNAM 2 YHP 6-OXO-1-PHENYL-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4- HETNAM 3 YHP B]PYRIDIN-5-YL]-3-(TRIFLUOROMETHYL)BENZAMIDE FORMUL 2 YHP C29 H25 F4 N5 O2 FORMUL 3 HOH *378(H2 O) HELIX 1 AA1 ASP A -9 TYR A -4 5 6 HELIX 2 AA2 ASN A 2 GLU A 11 1 10 HELIX 3 AA3 SER A 38 GLY A 51 1 14 HELIX 4 AA4 THR A 59 ARG A 80 1 22 HELIX 5 AA5 LEU A 84 LEU A 91 1 8 HELIX 6 AA6 ASP A 92 GLY A 113 1 22 HELIX 7 AA7 PHE A 114 GLN A 123 1 10 HELIX 8 AA8 ARG A 125 LYS A 135 1 11 HELIX 9 AA9 SER A 136 THR A 142 1 7 HELIX 10 AB1 THR A 142 GLY A 156 1 15 HELIX 11 AB2 TRP A 158 TYR A 1072 1 18 HELIX 12 AB3 GLY A 1082 LEU A 1093 1 12 HELIX 13 AB4 SER A 1099 PHE A 1109 1 11 HELIX 14 AB5 LYS A 1119 GLY A 1130 1 12 HELIX 15 AB6 SER A 1133 LEU A 1148 1 16 HELIX 16 AB7 GLU A 1150 LYS A 1166 1 17 HELIX 17 AB8 LEU A 1175 ASN A 1187 1 13 HELIX 18 AB9 PHE A 1192 GLU A 1202 1 11 HELIX 19 AC1 PRO A 1209 ILE A 1223 1 15 HELIX 20 AC2 PRO A 1237 ALA A 1247 1 11 HELIX 21 AC3 ALA A 1247 SER A 1256 1 10 SHEET 1 AA1 3 ARG A 14 LYS A 19 0 SHEET 2 AA1 3 TYR A 25 GLY A 28 -1 O THR A 26 N TYR A 18 SHEET 3 AA1 3 HIS A 31 THR A 34 -1 O LEU A 33 N TYR A 25 SHEET 1 AA2 3 LYS A1073 ASP A1074 0 SHEET 2 AA2 3 ASP A1077 ILE A1081 -1 O LYS A1080 N ASP A1074 SHEET 3 AA2 3 PHE A1117 SER A1118 -1 O PHE A1117 N ILE A1081 SHEET 1 AA3 2 LEU A1173 ASP A1174 0 SHEET 2 AA3 2 SER A1207 ILE A1208 -1 O ILE A1208 N LEU A1173 SITE 1 AC1 19 ILE A1086 PHE A1089 CYS A1090 PRO A1097 SITE 2 AC1 19 ALA A1098 SER A1099 VAL A1102 LEU A1103 SITE 3 AC1 19 ILE A1105 ALA A1106 GLN A1114 CYS A1115 SITE 4 AC1 19 GLU A1116 PHE A1117 PHE A1164 ALA A1180 SITE 5 AC1 19 TYR A1181 LEU A1184 HOH A1493 CRYST1 35.233 97.057 59.837 90.00 106.11 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028382 0.000000 0.008197 0.00000 SCALE2 0.000000 0.010303 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017395 0.00000